Alto Neuroscience says a study of its major depressive disorder investigational drug did not meet its primary endpoint.
Federal Register notice: FDA announces a 12/12 Vaccines and Related Biological Products Advisory Committee meeting to discuss considerations for pedia...
FDA warns Phoenix, AZ-based Pinnacle Transplant Technologies that it is illegally manufacturing and marketing amniotic products that have CGMP deviati...
Novo Nordisk asks FDA to add its semaglutide products to the lists of drugs that should not be compounded.
FDA approves an expanded indication for Pfizers Abrysvo RSV vaccine to include adults from age 18 and up.
A California man operating a company called Warrior Labz SARMs pleads guilty to selling unapproved drugs after receiving an FDA Warning Letter advisin...
FDA awards U.P. Oncolytics an orphan drug designation for its oncolytic virus-based therapy to treat malignant gliomas.
FDA warns Orange, CA-based neurologist Namita Goyal about violations found in a bioresearch monitoring inspection of a clinical trial she conducted.
